Show simple item record

Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK

dc.contributor.authorOxley, Samuel
dc.contributor.authorKalra, Ashwin
dc.contributor.authorSideris, Michail
dc.contributor.authorItzkowitz, Nicole
dc.contributor.authorEvans, Olivia
dc.contributor.authorAtakpa, Emma Christine
dc.contributor.authorBrentnall, Adam R
dc.contributor.authorDworschak, Nina
dc.contributor.authorGaba, Faiza
dc.contributor.authorGabe, Rhian
dc.contributor.authorSundar, Sudha
dc.contributor.authorWood, Nick
dc.contributor.authorNicum, Shibani
dc.contributor.authorTaylor, Alexandra
dc.contributor.authorDobbs, Stephen
dc.contributor.authorMcCluggage, W Glenn
dc.contributor.authorNordin, Andy
dc.contributor.authorLegood, Rosa
dc.contributor.authorKehoe, Sean
dc.contributor.authorGhaem-Maghami, Sadaf
dc.contributor.authorManchanda, Ranjit
dc.date.accessioned2024-06-08T23:16:46Z
dc.date.available2024-06-08T23:16:46Z
dc.date.issued2023-02-16
dc.identifier229416792
dc.identifierd25bd5bf-2436-4d5c-9b97-c8eab84eef3d
dc.identifier36831615
dc.identifier.citationOxley , S , Kalra , A , Sideris , M , Itzkowitz , N , Evans , O , Atakpa , E C , Brentnall , A R , Dworschak , N , Gaba , F , Gabe , R , Sundar , S , Wood , N , Nicum , S , Taylor , A , Dobbs , S , McCluggage , W G , Nordin , A , Legood , R , Kehoe , S , Ghaem-Maghami , S & Manchanda , R 2023 , ' Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK ' , Cancers , vol. 15 , no. 4 , 1273 . https://doi.org/10.3390/cancers15041273en
dc.identifier.issn2072-6694
dc.identifier.otherPubMedCentral: PMC9953843
dc.identifier.otherORCID: /0000-0003-4081-6883/work/131351861
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/20322
dc.descriptionFunding: This research was funded by the British Gynaecological Cancer Society (EMSG1L5R) and Ovacome charity. It is supported by the National Cancer Research Institute Gynaecological Cancer Clinical Studies Group and the British Association of Gynaecological Pathologists. The funding bodies had no role in the study design, data collection, analysis, interpretation or writing of the report, or decision to submit for publication. The research team was independent of funders. Acknowledgments: The study is supported by researchers at the Barts Cancer Research United Kingdom Centre for Excellence, Queen Mary University of London (C16420/A18066). We are grateful for the endorsement and support from charities and patient support groups such as Ovacome, The Eve Appeal, Target Ovarian Cancer, Ovarian Cancer Action, Jo’s Cervical Cancer Trust, and GO Girls. We are grateful for the support received from the Royal College of Obstetricians and Gynaecologists, the National Cancer Research Institute Gynaecological Cancer Clinical Studies Group, and the British Association of Gynaecological Pathologists.en
dc.format.extent13
dc.format.extent561011
dc.language.isoeng
dc.relation.ispartofCancersen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectCOVID-19en
dc.subjectmultidisciplinary teamen
dc.subjectgynaecological canceren
dc.subjectR Medicineen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.subject.lccRC0254en
dc.titleImpact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UKen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.3390/cancers15041273


Files in this item

Thumbnail
Name:
Bonini_etal_EAACI_Burden_Of_Il ...
Size:
227.9Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record